Amarin Corp Plcuk (AMRN) Net Cash Flow Growth (5y) (2015 - 2026)

Amarin Corp Plcuk (AMRN) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -15.26%
Dec 31, 2025 20.88%
Sep 30, 2025 -29.83%
Jun 30, 2025 17.57%
Mar 31, 2025 65.63%
Dec 31, 2024 -4.77%
Sep 30, 2024 -16.33%
Jun 30, 2024 -29.64%
Mar 31, 2024 18.99%
Dec 31, 2023 -19.39%
Sep 30, 2023 31.03%
Jun 30, 2023 28.85%
Mar 31, 2023 -19.86%
Dec 31, 2022 -36.93%
Sep 30, 2022 31.68%
Jun 30, 2022 23.16%
Mar 31, 2022 32.58%
Dec 31, 2021 29.26%
Sep 30, 2021 -33.94%
Jun 30, 2021 43.38%